Ranibizumab Pretreatment in Vitrectomy with Internal Limiting Membrane Peeling on Diabetic Macular Edema in Severe Proliferative Diabetic Retinopathy

AIM: To evaluate the efficacy of intravitreal ranibizumab (IVR) pretreatment for pars plana vitrectomy (PPV) with internal limiting membrane (ILM) peeling in severe proliferative diabetic retinopathy (PDR) combined with macular edema (ME). METHODS: Sixty-three patients with ME and PDR were divided i...

Descripción completa

Detalles Bibliográficos
Autores principales: Guan, Jian, Cai, Na, Liu, Li-Min, Zhao, Ning, Liu, Ning-ning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7261291/
https://www.ncbi.nlm.nih.gov/pubmed/32356244
http://dx.doi.org/10.1007/s13300-020-00822-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7261291/
https://www.ncbi.nlm.nih.gov/pubmed/32356244
http://dx.doi.org/10.1007/s13300-020-00822-0

Ejemplares similares